Architect Ca 125 Ii Assay
Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125). 510(k) K042731, from Fujirebio Diagnostics,Inc. (Malvern, PA). Product code LTK, class 2.
As of Nov 20, 2026, K042731 is an FDA 510(k) held by Fujirebio Diagnostics,Inc., substantially equivalent on Nov 19, 2004 after 49 days, with no recalls tied to it in FDA's recall database.
- Review time: 49 days
- Recalls: 0
- Cited as a predicate by: 2 devices
和731 Device Name: ARCHITECT® CA 125 II™ Assay Indications for Use
- Axsym Ca 125K964020 · Abbott Laboratories · Nov 4, 1997
- Cyfra 21-1 Eia Model 211-10K100831 · Fujirebio Diagnostics,Inc. · May 26, 2011
- HE4 Eia, Model: 404-10 USK072939 · Fujirebio Diagnostics,Inc. · Jun 9, 2008
- Access OV MonitorK240479 · Beckman Coulter, Inc. · May 10, 2024
- Immulite/Immulite 1000 Om-Ma, Immulite 2000 Om-MaK213510 · Siemens Healthcare Diagnostics Products, Ltd. · Sep 8, 2023
- VITROS Immuodiagnostic Products CA 125 II Reagent PackK221355 · Ortho Clinical Diagnostics · Dec 12, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Oct 1, 2004
- Review panel
- Immunology
- Regulation
- 21 CFR 866.6010
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files